Cited by 481Liver Disease Diagnosis and TreatmentLiver Diseases and ImmunityLiver physiology and pathology

The DOI matches its Crossref record.

Nonalcoholic Steatohepatitis

Elizabeth M. Brunt·2004·Seminars in Liver Disease

DOI 10.1055/s-2004-823098

Open this paper in CoChat — free account

Abstract

Nonalcoholic fatty liver disease (NAFLD) is being increasingly recognized as a common liver disorder that represents the hepatic manifestation of the metabolic syndrome, a variably defined aggregate of disorders related to obesity, insulin resistance, type II diabetes, hypertension and hyperlipidemia. Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a risk for progressive fibrosis, cirrhosis, and end-stage liver disease. Hepatocellular carcinoma (HCC) is a documented complication in an as yet unknown percentage of cases of NASH cirrhosis. The diagnosis of nonalcoholic steatohepatitis requires histopathologic evaluation because the lesions of parenchymal injury and fibrosis cannot be detected by imaging studies or laboratory tests. This article will briefly discuss prevalence studies and the pathophysiology of NAFLD and focus on current discussions related to the specific lesions in the pathology of NASH, including the challenges of pediatric NASH and NASH-related cirrhosis.

Integrity signals

Registry

Crossref · 10.1055/s-2004-823098

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 301–400 of 480

Usefulness of Gd‐EOB‐DTPA‐enhanced MR imaging in the evaluation of simple steatosis and nonalcoholic steatohepatitis
Wu, Z., Matsui, O., Kitao, A., et al. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23921 · Cited by 25
The genetics of nonalcoholic fatty liver disease
Österreicher, C. H., & Brenner, D. A. (2007) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31936-2 · Cited by 25
Standardized Prevalence Ratios for Chronic Hepatitis C Virus Infection Among Adult Japanese Hemodialysis Patients
Ohsawa, M., Kato, K., Itai, K., et al. (2010) · Journal of Epidemiology · doi:10.2188/jea.je20090043 · Cited by 24
Liver damage is not reversed during the lean period in diet‐induced weight cycling in mice
Barbosa‐da‐Silva, S., da Silva, N. C., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2013) · Hepatology Research · doi:10.1111/hepr.12138 · Cited by 24
Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N-methyltransferase
van der Veen, J. N., Lingrell, S., Gao, X., Takawale, A. R., Kassiri, Z., Vance, D. E., & Jacobs, R. L. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m070631 · Cited by 27
ERp57 is up‐regulated in free fatty acids‐induced steatotic L‐02 cells and human nonalcoholic fatty livers
Wang, H., Chan, P., Pan, S., et al. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22696 · Cited by 24
Early changes in the liver‐soluble proteome from mice fed a nonalcoholic steatohepatitis inducing diet
Thomas, A., Stevens, A. P., Klein, M. S., Hellerbrand, C., Dettmer, K., Gronwald, W., Oefner, P. J., & Reinders, J. (2012) · PROTEOMICS · doi:10.1002/pmic.201100628 · Cited by 24
Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: Differences and similarities
Persico, M., Masarone, M., Mura, V. L., Persico, E., Moschella, F., Svelto, M., Bruno, S., & Torella, R. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.462 · Cited by 24
Wisteria floribunda agglutinin‐positive Mac‐2 binding protein predicts the development of hepatocellular carcinoma in patients with non‐alcoholic fatty liver disease
Kawanaka, M., Tomiyama, Y., Hyogo, H., Koda, M., Shima, T., Tobita, H., Hiramatsu, A., Nishino, K., Okamoto, T., Sato, S., et al. (2018) · Hepatology Research · doi:10.1111/hepr.13054 · Cited by 23
Molecular determinants of insulin resistance, cell apoptosis and lipid accumulation in non-alcoholic steatohepatitis
Piro, S., Spadaro, L., Russello, M., Spampinato, D., Oliveri, C. E., Vasquez, E., Benigno, R., Brancato, F., Purrello, F., & Rabuazzo, A. M. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.08.002 · Cited by 22
Importance of the liver ultrasound scores in pubertal obese children with nonalcoholic fatty liver disease
Akçam, M., Boyacı, A., Pirgon, Ö., et al. (2012) · Clinical Imaging · doi:10.1016/j.clinimag.2012.07.011 · Cited by 21
An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials
Leow, W. Q., Bédossa, P., Liu, F., Wei, L., Lim, K., Wan, W., Ren, Y., Chang, J. P.-E., Tan, C., Wee, A., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10090643 · Cited by 21
Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model
Song, Y., Kim, S., Heo, J., Shum, D., Lee, S., Lee, M., Kim, A., & Seo, H. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-90263-x · Cited by 24
The combination of S-adenosylmethionine and dilinoleoylphosphatidylcholine attenuates nonalcoholic steatohepatitis produced by a high-fat diet in rats
Lieber, C. S., Leo, M. A., Cao, Q., Mak, K. M., Ren, C., Ponomarenko, A. N., Wang, X., & DeCarli, L. M. (2007) · Nutrition Research · doi:10.1016/j.nutres.2007.07.005 · Cited by 21
n‐3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis
Provenzano, A., Milani, S., Vizzutti, F., Delogu, W., Navari, N., Novo, E., Maggiora, M., Maurino, V., Laffi, G., Parola, M., et al. (2014) · Liver International · doi:10.1111/liv.12500 · Cited by 20
Epigallocatechin-3-Gallate Toxicity in Children: A Potential and Current Toxicological Event in the Differential Diagnosis With Virus-Triggered Fulminant Hepatic Failure
Sergi, C. M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01563 · Cited by 21
“Also, the increased rate of obesity in Western countries does not spare childhood and youth, and the number of parents using nutraceuticals and natural remedies for pediatric obesity or illness is vastly increasing worldwide (Brunt, 2004; Hartman and Shamir, 2012).”
Background
Genistein Modulated Lipid Metabolism, Hepatic PPARγ, and Adiponectin Expression in Bilateral Ovariectomized Rats with Nonalcoholic Steatohepatitis (NASH)
Pummoung, S., Werawatganon, D., Chayanupatkul, M., Klaikeaw, N., & Siriviriyakul, P. (2020) · Antioxidants · doi:10.3390/antiox10010024 · Cited by 21
Anthropometric and Biochemical Characteristics of Patients with Nonalcoholic Fatty Liver Diagnosed by Non-Invasive Diagnostic Methods
Novaković, T., Mekić, M., Smilic, L., Smilic, T. N., Ini, B., Kostic, K., Jovićević, L., Mirković, Z., & Milinić, S. (2014) · Medical Archives · doi:10.5455/medarh.2014.68.22-26 · Cited by 20
MCPIP1 Inhibits Hepatic Stellate Cell Activation in Autocrine and Paracrine Manners, Preventing Liver Fibrosis
Pydyn, N., Ferenc, A., Trzos, K., Pośpiech, E., Wilamowski, M., Mucha, O., Major, P., Kadłuczka, J., Rodrigues, P. M., Bañales, J. M., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.021 · Cited by 19
Long‐term prognosis of nonalcoholic fatty liver disease: Is pharmacological therapy actually necessary?
Çınar, K., Çoban, Ş., Idılman, R., Tüzün, A. E., Sarioğlu, M., Bektaş, M., Erden, E., Bozkaya, H., & Özden, A. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04221.x · Cited by 19
Non-alcoholic steatohepatitis: An update in pathophysiology, diagnosis and therapy
Khedmat, H., & Taheri, S. (2011) · Hepatitis Monthly · Cited by 19
Markers in Nonalcoholic Steatohepatitis
Armutçu, F., Akyol, S., Uçar, F., Erdoğan, S., & Akyol, Ö. (2013) · Advances in clinical chemistry · doi:10.1016/b978-0-12-407680-8.00004-x · Cited by 19
Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis
Sayıner, M., Lam, B. P., Golabi, P., & Younossi, Z. M. (2018) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818811508 · Cited by 20
Prevalence of esophagogastric varices in patients with non‐alcoholic steatohepatitis
Nakamura, S., Konishi, H., Kishino, M., et al. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00318.x · Cited by 19
Systems Level Metabolic Phenotype of Methotrexate Administration in the Context of Non-alcoholic Steatohepatitis in the Rat
Kyriakides, M. A., Hardwick, R. N., Jin, Z., et al. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu160 · Cited by 18
Overview: An Introduction to NASH and Related Fatty Liver Disorders
Farrell, G. C., George, J., Hall, P. D. L. Μ., & McCullough, A. J. (2004) · doi:10.1002/9780470987438.ch1 · Cited by 18
Effect of pioglitazone, quercetin, and hydroxy citric acid on vascular endothelial growth factor messenger RNA (VEGF mRNA) expression in experimentally induced nonalcoholic steatohepatitis (NASH)
Surapaneni, K. M., Veeraraghavan, V. P., & Jainu, M. (2015) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1404-136 · Cited by 17
Intermittent Fasting Alleviates Non‐Alcoholic Steatohepatitis by Regulating Bile Acid Metabolism and Promoting Fecal Bile Acid Excretion in High‐Fat and High‐Cholesterol Diet Fed Mice
Lin, X., Zhu, X., Xin, Y., Zhang, P., Xiao, Y., He, T., & Guo, H. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200595 · Cited by 18
Macaca radiata (bonnet monkey): a spontaneous model of nonalcoholic fatty liver disease
Nagarajan, P., Venkatesan, R., Kumar, M., et al. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01706.x · Cited by 17
Acetone fraction from Sechium edule (Jacq.) S.w. edible roots exhibits anti-endothelial dysfunction activity
Trejo-Moreno, C., Castro-Martínez, G., Méndez-Martínez, M., Jiménez‐Ferrer, E., Pedraza‐Chaverrí, J., Arrellín, G., Zamilpa, A., Medina‐Campos, O. N., Lombardo-Earl, G., Barrita-Cruz, G. J., et al. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.02.036 · Cited by 19
Neurotherapeutic effect of allopurinol against brain injury in hyperlipidemic rats
Abeer, A. A. S., & Bassant, M. M. I. (2015) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp2014.4247 · Cited by 17
Non-alcoholic Steatohepatitis in a Sample of Iranian Adult Population: Age is a Risk Factor.
Rogha, M., Najafi, N., Azari, A., et al. (2011) · PubMed · Cited by 17
Anti-fibrotic Effects of a Methylenedioxybenzene Compound, CW209292 on Dimethylnitrosamine-Induced Hepatic Fibrosis in Rats
Oh, S., Kim, D., Ha, J.-R., & Kim, D.-Y. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1364 · Cited by 17
Association between Abnormal Liver Function and Risk Factors for Metabolic Syndrome among Freshmen
Tsai, P.-Y., Yen, C., Li, Y.-C., et al. (2007) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2007.03.002 · Cited by 17
[Prevalence of non-alcoholic steatohepatitis. Comparative study with diabetic patients].
Bernal-Reyes, R., Sáenz-Labra, A., & Bernardo-Escudero, R. (2001) · PubMed · Cited by 17
A State-of-the-Art Review on the Evolving Utility of Endoscopic Ultrasound in Liver Diseases Diagnosis
Sbeit, W., Kadah, A., Mahamid, M., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10080512 · Cited by 16
Host immune response in chronic hepatitis C infection: involvement of cytokines and inflammasomes
Boldeanu, M. V., Medico Science SRL – Stem Cell Bank Unit, C., Siloşi, I., Bărbulescu, A. L., Sandu, R. E., Geormăneanu, C., Pădureanu, V., Popescu-Drigă, M. V., Poenariu, I. S., Siloşi, C. A., et al. (2020) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.1.04 · Cited by 15
Inhibition of DNA-dependent protein kinase reduced palmitate and oleate-induced lipid accumulation in HepG2 cells
Kwan, H. Y., Fong, W. F., Yang, Z., et al. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0467-5 · Cited by 16
Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan
Sumida, Y. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i10.374 · Cited by 16
Evaluation of fatty liver fibrosis in rabbits using real-time shear wave elastography
Lu, Y., Jia, W. P., Tang, Y., et al. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1749 · Cited by 16
Acarbose is a promising therapeutic strategy for the treatment of patients with nonalcoholic steatohepatitis (NASH)
Yamagishi, S., Nakamura, K., & Inoue, H. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.01.032 · Cited by 16
Low 25-hydroxyvitamin D level is not an independent risk factor for hepatosteatosis in obese children
Sezer, O. B., Buluş, D., Hızlı, Ş., Andıran, N., Yılmaz, D., & Ramadan, S. U. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0426 · Cited by 16
Non‐invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta
Kalkan, Ç., Yılmaz, Y., Erdoğan, B. D., Savaş, B., Yurdcu, E., Çalışkan, A., Keskın, O., Gençdal, G., Zeybel, M., Törüner, M., et al. (2023) · Journal of Viral Hepatitis · doi:10.1111/jvh.13806 · Cited by 15
Diabetes Mellitus: Treatment Challenges and the Role of Some Herbal Therapies
Sakthiswary, R., Zakaria, Z., & Das, S. (2014) · Middle-East Journal of Scientific Research · doi:10.5829/idosi.mejsr.2014.20.07.82226 · Cited by 15
Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation
Khaleel, E. F., & Abdel‐Aleem, G. A. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1437638 · Cited by 15
Emerging drugs for non-alcoholic steatohepatitis
Tomeno, W., Yoneda, M., Imajo, K., Ogawa, Y., Kessoku, T., Saito, S., Eguchi, Y., & Nakajima, A. (2013) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2013.811232 · Cited by 15
Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future?
Hatton, G. B., Alterio, T., Nobili, V., & Mann, J. P. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1512853 · Cited by 15
Serum paraoxonase and arylesterase activities in Iranian patients with nonalcoholic fatty liver disease
Hashemi, M. M., Bahari, A., Hashemzehi, N., et al. (2012) · Pathophysiology · doi:10.1016/j.pathophys.2012.04.001 · Cited by 14
Use of noninvasive scores for advanced liver fibrosis can guide the need for hepatic biopsy during bariatric procedures
Udelsman, B. V., Corey, K. E., Hutter, M. M., Chang, D. C., & Witkowski, E. R. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.09.037 · Cited by 14
The Utility of Xenon-133 Liver Scan in the Diagnosis and Management of Nonalcoholic Fatty Liver Disease
Al‐Busafi, S. A., Ghali, P., Wong, P. Y. N., Novales-Diaz, J. A., & Deschênes, M. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/796313 · Cited by 14
Diazoxide prevents abdominal adiposity and fatty liver in obese OLETF rats at prediabetic stage
Guo, Z., Bu, S., Yu, Y., Ghatnekar, G. S., Wang, M., Chen, L., Bu, M., Yang, L., Zhu, B., Feng, Z., et al. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.08.005 · Cited by 14
Pathology of fatty liver: differential diagnosis of non-alcoholic fatty liver disease
Yeh, M. M., & Brunt, E. M. (2008) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2008.09.005 · Cited by 14
Self-citation
The Application of Berberine in Fibrosis and the Related Diseases
Gao, R., Lu, Y., Zhang, W., & Zhang, Z. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500307 · Cited by 13
Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma
Shin, S. K., Oh, S., Chun, S., Ahn, M., Lee, S., Kim, K.-S., Kang, H., Lee, J., Shin, S. P., Lee, J., et al. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16584 · Cited by 15
“Thus, thorough understandings of these immune processes are required to utilize NK cells or NK cell-related signaling pathways for the proper management of NAFLD-or NASH-related LC and HCC. 14”
Influential
FACTORS RELATED TO NON‐ALCOHOLIC FATTY LIVER DISEASE IN OBESE CHILDREN
Dalgıç, B., Çamurdan, M., Eminoglu, F., et al. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2006.tb01741.x · Cited by 13
Hepatocyte growth factor, adiponectin and hepatic histopathology in non-alcoholic steatohepatitis.
Agrawal, R., Sheroan, V., Ola, V., et al. (2013) · PubMed · Cited by 13
A Lipid-Based Nanocarrier Containing Active Vitamin D3 Ameliorates NASH in Mice via Direct and Intestine-Mediated Effects on Liver Inflammation
Mu, Y., Li, J., Kang, J., Eto, H., Zai, K., Kishimura, A., Hyodo, F., Mori, T., & Katayama, Y. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00432 · Cited by 13
Dysmetabolic iron overload syndrome.
Fargion, S. R. (1999) · PubMed · Cited by 13
The Possibility of Differentiation between Nonalcoholic Steatohepatitis and Fatty Liver in Rabbits on Gd-EOB-DTPA-enhanced Open-type MRI Scans
Sonoda, A., Nitta, N., Ohta, S., et al. (2011) · Academic Radiology · doi:10.1016/j.acra.2010.11.018 · Cited by 12
Fatty Liver Disease
Brunt, E. M., & TINIAKOS, D. G. (2009) · Elsevier eBooks · doi:10.1016/b978-141604059-0.50044-8 · Cited by 12
Self-citation
The Fatty Liver Index’s Association with Incident Chronic Kidney Disease in Korean Middle-Aged Adults: A Community-Based Cohort Study
Lee, H. H., Ro, H., Jung, J. Y., Chang, J. H., Chung, W., & Kim, A. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061616 · Cited by 11
“NAFLD encompasses a wide range of liver diseases, from simple steatosis to nonalcoholic steatohepatitis (NASH) and liver cirrhosis, followed by hepatocellular carcinoma [11,12].”
Background
Visceral Adiposity, Anthropometric and Liver Function Indexes for Identifying Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in Adolescents with Obesity: Which Performs Better?
Mari, L., Lazzer, S., Gatti, A., D’Alleva, M., Zaccaron, S., Stafuzza, J., Rejc, E., Vandoni, M., Bondesan, A., Caroli, D., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14062085 · Cited by 12
“Then, gastroenterology experts evaluated the following ultrasound image features and made the final diagnosis, including hepatorenal echo contrast (0–4 points), depth attenuation (0–2 points), liver brightness (0–4 points), and vascular blurring (0–2 points) [3].”
Influential
Influence of type 2 diabetes mellitus on liver histology among morbidly obese individuals. A cross-sectional study
Cazzo, E., Jimenez, L. S., JÚNIOR, F. G., Pareja, J. C., & Chaim, É. A. (2016) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2015.01652409 · Cited by 11
Modelo experimental de esteatohepatite não-alcoólica com dieta deficiente em metionina e colina
Zamin, I., de Mattos, Â. A., de Mattos, Â. Z., Migon, E., Soares, E., & Perry, M. L. S. (2009) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032009000100017 · Cited by 11
Psammomys obesus, a unique model of metabolic syndrome, inflammation and autophagy in the pathologic development of hepatic steatosis
Sihali-Beloui, O., El-Aoufi, S., Maouche, B., & Marco, S. (2016) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2016.08.001 · Cited by 10
Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study
Federico, A., Masarone, M., Romano, M., Dallio, M., Rosato, V., & Persico, M. (2015) · Hepatitis Monthly · doi:10.5812/hepatmon.15(6)2015.18640 · Cited by 9
Non-alcoholic steatohepatitis: physiopathological, clinical and therapeutic implications
Pérez-Aguilar, F., Benlloch, S., Berenguer, M., Beltrán, B., & Berenguer, J. (2004) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082004000900006 · Cited by 9
Adiponectin normalization: a clue to the anti-metabolic syndrome action of rimonabant
Maynadier, M., Basile, I., & Gary‐Bobo, M. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.09.009 · Cited by 9
The association of insomnia with gastroesophageal reflux symptoms in biopsy-proven nonalcoholic fatty liver disease
Japan Study Group of NAFLD (JSG-NAFLD), Taketani, H., Sumida, Y., Tanaka, S., Imajo, K., Yoneda, M., Hyogo, H., Ono, M., Fujii, H., Eguchi, Y., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0871-5 · Cited by 9
Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV‐related chronic liver disease
Masarone, M., Mura, V. L., Bruno, S., et al. (2007) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2007.00861.x · Cited by 9
Nonalcoholic Fatty Liver Disease: Changes in Gut Microbiota and Blood Lipids
Yang, K., Zeng, J., Wu, H., Liu, H., Ding, Z., Liang, W., Wu, L., Lin, Z., Huang, W., Xu, J., et al. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00199 · Cited by 8
Anterograde synaptic transport of neuronal tracer enzyme (WGA-HRP): further studies with Rab3A-siRNA in rats
Takeuchi, Y., Matsumoto, Y., Miki, T., YOKOYAMA, T., Warita, K., Wang, Z., Ueno, T., Yakura, T., & Fujita, M. (2009) · Biomedical Research - India · doi:10.4103/0970-938x.54832 · Cited by 8
Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development
M. S. Barron, A., Fabre, T., & De, S. (2024) · F1000Research · doi:10.12688/f1000research.143472.1 · Cited by 8
Palmiwon attenuates hepatic lipid accumulation and hyperlipidemia in a menopausal rat model
Go, H., Ryuk, J. A., Lee, H. W., et al. (2015) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000395 · Cited by 8
Indigenous Herbal Recipes for Treatment of Liver Cirrhosis
Wijayagunawardane, M. P. B., Wijerathne, C. U. B., & Herath, C. B. (2015) · Procedia Chemistry · doi:10.1016/j.proche.2015.03.038 · Cited by 8
Fundamento molecular de la esteatosis hepática asociada a la obesidad
Buqué, X., Aspichueta, P., & Ochoa, B. (2008) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082008000900007 · Cited by 9
The Impact of Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome on Progression of Fibrosis in Patients With Recurrent HCV After Liver Transplantation
Mindikoglu, A. L., Regev, A., Casanova-Romero, P. Y., et al. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.02.060 · Cited by 8
Fatty Liver Disease
TINIAKOS, D. G., Anstee, Q. M., Brunt, E. M., & Burt, A. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00005-3 · Cited by 7
Self-citation
Hepatic Steatosis Analysis in Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Artificial Intelligence
Wang, X., Song, Y., Jin, R., Wang, Z., Li, X., Yang, Q., Teng, X., Liu, F., Wu, N., Xie, Y., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14242889 · Cited by 7
Hepatocellular Ballooning is Due to Highly Pronounced Glycogenosis Potentially Associated with Steatosis and Metabolic Reprogramming
Ribback, S., Peters, K., Yasser, M., Prey, J., Wilhelmi, P., Su, Q., Dombrowski, F., & Bannasch, P. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00242 · Cited by 8
Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
Bi, Y., Min, M., Shen, W., Deng, P., Du, Q., Dong, M., & Liu, Y. (2015) · PubMed Central · Cited by 7
OCCURRENCE AND SIGNIFICANCE OF MALLORY BODIES IN MORBIDLY OBESE PATIENTS
Gluud, C. N., Christoffersen, P., ANDERSEN, T., Morton, J. A., & McGee, J. O. (1984) · Acta Pathologica Microbiologica Scandinavica Series A Pathology · doi:10.1111/j.1699-0463.1984.tb04375.x · Cited by 7
Improvement of NASH with two-year Treatment with oral polyenephosphatidylcholine
Ohbayashi, H., Fujimoto, M., YAMASE, H., & Ito, M. (2007) · Journal of Rural Medicine · doi:10.2185/jrm.2.67 · Cited by 6
Hígado graso no alcohólico en niños obesos
Torres, L. P., Lamas, R. P., Arbelo, T. F., et al. (2006) · Revista cubana de pediatría · Cited by 6
Hepatic fat quantification using automated six-point Dixon: Comparison with conventional chemical shift based sequences and computed tomography
Shimizu, K., Namimoto, T., Nakagawa, M., et al. (2017) · Clinical Imaging · doi:10.1016/j.clinimag.2017.06.006 · Cited by 6
Prolonged hepatitis caused by cytomegalovirus and non-alcoholic steatohepatitis in 16-year-old obese boy
Kanda, T., Yokosuka, O., & Suzuki, Y. (2005) · European Journal of Pediatrics · doi:10.1007/s00431-004-1584-9 · Cited by 6
Transitional features of histologic type of non‐alcoholic fatty liver disease in Korean young men
Kim, J. K., Chon, N. R., Lim, H. C., Lee, K. S., Han, K., Chon, C. Y., Park, Y. N., & Paik, Y. H. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06895.x · Cited by 6
Nonalcoholic Fatty Liver Disease Manifesting Esophageal Variceal Bleeding
Tang, C.-P., Huang, Y., Tsay, S., et al. (2006) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(09)70201-1 · Cited by 6
Medex Test, a Novel Modality for Liver Disease Diagnosis
Lurie, Y., Landau, D., Kanevsky, A., Pel, S., Zelber‐Sagie, S., & Oren, R. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225641.83275.6a · Cited by 6
Esteatosis hepática no alcohólica. Puesta al día
Caballería, L., Torán‐Monserrat, P., Llorens, M. A. A., & Pera, G. (2008) · Atención Primaria · doi:10.1157/13125408 · Cited by 6
Genetics of Hepatobiliary Diseases
Juran, B. D., & Lazaridis, K. N. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.004 · Cited by 6
Estado actual de la esteatohepatitis no alcohólica
Ricote, G. C., & Monzón, C. G. (2003) · Medicina Clínica · doi:10.1016/s0025-7753(03)73870-6 · Cited by 6
Prevalence of non-alcoholic fatty liver disease (NAFLD) in a cohort of patients with type 2 diabetes: the PHIGNA-DM2 study
García‐Luna, P. P., Martínez-Ortega, A. J., Piñar-Gutiérrez, A., Lara, C., Remón-Ruiz, P., Herrojo, J. A., de Lara-Rodríguez, I., Romero‐Gómez, M., & Soto‐Moreno, A. (2022) · Nutrición Hospitalaria · doi:10.20960/nh.03969 · Cited by 5
CD4+CD25+Foxp3+ Regulatory T Cells Contribute in Liver Fibrosis Improvement with Interferon Alpha
Li, F., Kang, H., Liu, L. N., & Cao, Y. (2013) · Inflammation · doi:10.1007/s10753-013-9677-0 · Cited by 5
Nonalcoholic Fatty Liver Disease
Lackner, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-42873-6.00012-3 · Cited by 7
[A case of non-alcoholic fatty liver disease (NAFLD) aggravated after treatment with raloxifene].
Matsumura, M., Tashiro, K., Miura, A., et al. (2011) · PubMed · Cited by 5
Abnormal liver test results on routine screening
Mallory, M. A., Lee, S. W., & Kowdley, K. V. (2004) · Postgraduate Medicine · doi:10.3810/pgm.2004.03.1461 · Cited by 5
Hepatic Steatosis in Iranian Patients with Chronic Hepatitis C
Minakari, M., Sameni, F. K., Shalmani, H. M., Molaee, M., & Zali, M. R. (2008) · Medical Principles and Practice · doi:10.1159/000112966 · Cited by 6
Les stéatopathies métaboliques : conséquences hépatiques du syndrome métabolique
Anty, R., Gual, P., Huet, P., MARCHAND‐BRUSTEL, Y. L., & Tran, A. (2007) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(07)78350-1 · Cited by 5
Biochemical changes in alcoholic hepatitis with phyllanthus amarus therapy: A study
Nikam, P., Nikam, S., Sontakke, A. V., et al. (2009) · Biomedical Research - India · doi:10.4103/0970-938x.54840 · Cited by 5

Authors: Brunt, E. M.
Affiliations: Saint Louis University Hospital (US)
Corresponding author: Elizabeth M. Brunt
ORCID: Elizabeth M. Brunt
Venue: Seminars in Liver Disease
Publisher: Georg Thieme Verlag KG
Published: 2004-01
Volume: 24
Issue: 1
Pages: 3-20
ISSN: 0272-8087 (ISSN-L)
1098-8971
DOI: 10.1055/s-2004-823098
OpenAlex: W3149847267
Cited by: 481
References: 0
Citations by year: 2026: 2 · 2025: 2 · 2024: 9 · 2023: 8 · 2022: 4 · 2021: 6 · 2020: 13 · 2019: 4 · 2018: 18 · 2017: 14 · 2016: 24 · 2015: 25 · 2014: 26 · 2013: 22 · 2012: 31
FWCI: 29.48
Type: journal article
Language: en
Open access: closed
Locations: Seminars in Liver Disease (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, metabolic syndrome, liver fibrosis, liver cirrhosis, hepatocellular carcinoma, histopathology, pathophysiology, prevalence, insulin resistance, obesity
MeSH terms: Adolescent, Adult, Child, Fatty Liver, Fatty Liver, Alcoholic, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Prevalence, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nonalcoholic Steatohepatitis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks